We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

3 hedge funds and large institutions have $19.3M invested in Plus Therapeutics in 2015 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

158% more capital invested

Capital invested by funds: $7.5M → $19.3M (+$11.8M)

25% less funds holding

Funds holding: 43 (-1)

57% less call options, than puts

Call options by funds: $16K | Put options by funds: $37K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
1
Calls
$16K
Puts
$37K
Net Calls
-$21K
Net Calls Change
-$20K
Name Holding Trade Value Shares
Change
Change in
Stake
BIT
1
BlackRock Institutional Trust
California
$4.14M
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.31M
BFA
3
BlackRock Fund Advisors
California
$2.65M
PCM
4
Perkins Capital Management
Minnesota
$1.55M
State Street
5
State Street
Massachusetts
$1.11M
Northern Trust
6
Northern Trust
Illinois
$915K
Goldman Sachs
7
Goldman Sachs
New York
$683K
Geode Capital Management
8
Geode Capital Management
Massachusetts
$527K
PCMI
9
Princeton Capital Management Inc
New Jersey
$483K
TCIM
10
TIAA CREF Investment Management
New York
$456K
Bank of New York Mellon
11
Bank of New York Mellon
New York
$447K
MCM
12
Marathon Capital Management
Maryland
$376K
BIM
13
BlackRock Investment Management
Delaware
$329K
California State Teachers Retirement System (CalSTRS)
14
California State Teachers Retirement System (CalSTRS)
California
$201K
RAM
15
Redmond Asset Management
Virginia
$200K
TA
16
Teachers Advisors
New York
$170K
CB
17
Commerce Bank
Missouri
$163K
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$147K
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$140K
RhumbLine Advisers
20
RhumbLine Advisers
Massachusetts
$103K
Charles Schwab
21
Charles Schwab
California
$93K
BA
22
BlackRock Advisors
Delaware
$77K
OC
23
Oppenheimer & Co
New York
$77K
NFA
24
Nationwide Fund Advisors
Ohio
$69K
NFG
25
Noven Financial Group
Colorado
$62K

PSTV Hedge Fund Activity: Q1 2015 in Review

3 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2015, worth a combined $19.3M — up 158% from $7.5M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PSTV and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Sabby Management, exiting entirely with an estimated $2.19M sold.

  • 3 institutional investors held Plus Therapeutics (PSTV) as of Q1 2015, down from 4 in Q4 2014.
  • Funds reported $19.3M of Plus Therapeutics stock for Q1 2015, up 158% quarter-over-quarter.
  • 0 funds opened new Plus Therapeutics positions in Q1 2015 and 1 closed out, a net change of -1 holder.
  • The largest Plus Therapeutics seller in Q1 2015 was Sabby Management, an estimated $2.19M sold.

Based on aggregated 13F filings for Q1 2015.